Zila Articles
Burst of M&A activity in pharma during 2009 led by mega-deals from Pfizer/Wyeth and Merck & Co/S-P
4 February 2010
Pharmaceutical M&A deals in 2009
4 February 2010
Zila's 3rd-qtr fiscal 2007 loss reduced
2 July 2007
3rd qtr net losses widen at Zila
21 June 2004
Zila settles for $20M with former CRO
7 July 2003
Zila gets $20m in CRO dispute
21 April 2003
Zila reports $8.8M 4th qtr revenues
12 August 2002
Zila's 52% revenue increase; 54% cut in losses
24 June 2002
Zila gets $4M for remaining dental supply operations
24 June 2002
New president for Zila Pharma
20 May 1999
Zila Acquires Oxycal Labs
13 November 1997
Zila Deal
17 April 1995
WORLD NEWS IN BRIEF
17 May 1993
ZILA MARKETS ORASCAN
7 December 1992
Showing 1-15 of 15 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
